GONABREED DIN 02496763
Status: Marketed
Holder: PARNELL TECHNOLOGIES PTY LTD
Health Canada record
| Active ingredient(s) | GONADORELIN ACETATE 100 MCG |
|---|
| Dosage form | Solution |
|---|
| Route | Intramuscular |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 13-Jun-2023 |
|---|
| Current status date | 13-Jun-2023 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GONADORELIN ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02030314 | FERTILINE | VETOQUINOL N A INC | Solution | GONADORELIN ACETATE 50 MCG | Marketed |
| 02046202 | LUTREPULSE | FERRING INC | Powder For Solution | GONADORELIN ACETATE 3.2 MG | Dormant |
| 02046210 | LUTREPULSE PWS 0.8MG/VIAL | FERRING INC | Powder For Solution | GONADORELIN ACETATE 0.8 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 23287 | 2020-03-03 | New Drug Submission (NDS) | |
International API supply for GONADORELIN ACETATE
4 valid EDQM Certificates of Suitability from 4 holders. 2 active FDA Drug Master Files.
Request a quote for GONABREED
How to read a Canadian DIN record